Samir N.. Khleif, MD

Dr. Samir N. Khleif is a pioneer in the field of immunotherapy. He is a medical oncologist, immunologist, innovator, and entrepreneur, as well as a transformational executive in health care and biomedical research. Prior to becoming CEO of Georgiamune, Dr. Khleif served in different academic and leadership positions. He was a National Cancer Institute (NCI)/National Institutes of Health (NIH) scientist and Chief of the NCI Cancer Vaccine Section, where he led the development of pioneering immune-oncology and cancer vaccines into clinical trials. As a national and international academic leader, and detailed by the US government, he served as founding director and CEO of the King Hussein Cancer Center in Amman, Jordan, where he led the development of the largest cancer center in the MENA region. He also served as director of the Georgia Cancer Center at Augusta University. He is currently a biomedical scholar and holds a professorship at Georgetown University Medical School. Dr. Khleif also served as Special Assistant to the Commissioner of the FDA, leading the Critical Path Initiative for Oncology. He has served on the scientific advisory board of over 20 biotechnology and pharmaceutical companies. He is currently an advisor for the Parker Institute for Cancer Immunotherapy.